Actively Recruiting
a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer
Led by ARNAS Civico Di Cristina Benfratelli Hospital · Updated on 2025-06-25
60
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
Sponsors
A
ARNAS Civico Di Cristina Benfratelli Hospital
Lead Sponsor
A
Accuray Incorporated
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer
CONDITIONS
Official Title
a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-80 years
- ECOG performance status of 2 or less, or Karnofsky performance status of 70% or higher
- Diagnosed with endometrial cancer (endometrioid, serous cell, clear cell, carcinosarcoma) FIGO stage IB to IIIC1
- Candidates for post-operative external beam radiotherapy based on molecular and histological findings
- Patients may receive chemotherapy and/or brachytherapy
- Written informed consent provided
You will not qualify if you...
- Prior pelvic radiotherapy
- Para-aortic lymph node involvement
- ECOG performance status of 3 or higher
- Diagnosis of inflammatory bowel disease (active or quiescent)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
ARNAS Civico Hospital
Palermo, Italy, 90100
Not Yet Recruiting
2
ARNAS Civico Hospital
Palermo, Italy
Actively Recruiting
Research Team
F
FRANCESCO CUCCIA, MD
CONTACT
G
GIUSEPPE FERRERA, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here